Sort
261,768 grants matching “gene therapy”
Modulation of Therapeutic Response
$1,752,978James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Antisocial Drug Dependence: Genetics
$1,752,872University Of Colorado Denver · P60 · FY2005 · DA
PROTECT (Harnessing PROTEin degradation for Advanced Childhood Tumors)
$1,752,813Kimberly Stegmaier · Dana-Farber Cancer Inst · OT2 · FY2025 · CA
Developing Efficient and Safe Gene Transfer to Primate Hematopoietic Stem Cells
$1,752,245Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Washington University Human Tumor Atlas Research Center
$1,752,191Li Ding · Washington University · U2C · FY2018 · CA
Brain Imaging, APOE & the Preclinical Course of Alzheimer's Disease
$1,752,021Eric M Reiman · Banner Alzheimer'S Institute · R01 · FY2016 · AG
RETROVIRUSES AND CANCER GENES
$1,751,380University Of California San Francisco · R35 · FY2000 · CA
Integrated EGFR function in cytokine-driven inflammation and cancer
$1,751,310George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · CA
PPG-GENE THERAPY FOR CYSTIC FIBROSIS LUNG DISEASE
$1,751,292Michael J. Welsh · University Of Iowa · P01 · FY2008 · HL
APOBEC MUTAGENESIS IN BREAST CANCER
$1,751,218Reuben S Harris · University Of Texas Hlth Science Center · P01 · FY2022 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,751,169Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2011 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,751,169Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Dissecting the role of NEU1-dependent de-sialylation in neurodegeneration and neuroinflammation
$1,750,578Alessandra D'azzo · St. Jude Children'S Research Hospital · RF1 · FY2021 · NS
Molecular Chaperones and DNA Replication
$1,750,477Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Johns Hopkins Alzheimer's Disease Research Center
$1,749,916Marilyn S Albert · Johns Hopkins University · P50 · FY2013 · AG
A New and Disruptive Gene Based Therapy for Atrial Fibrillation
$1,749,913Robert Charles Moen · Inomagen Therapeutics, Inc · R44 · FY2023 · HL
Mayo Clinic Ovarian Cancer SPORE
$1,749,801Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2022 · CA
Molecular Circuits in the Hematopoietic Stem Cell Niche
$1,749,532George Q Daley · Boston Children'S Hospital · RC2 · FY2020 · DK
The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease
$1,749,426Katrin I Andreasson · Stanford University · RF1 · FY2022 · AG
FUNCTIONAL GENOMICS OF THE BETA-CELL
$1,749,404University Of Pennsylvania · U01 · FY2003 · DK
Molecular Characterization Of The Mitochondrial Dna Polymerase
$1,749,234William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Integrative Biology of Tumor Metastasis
$1,748,429Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2008 · CA
Mechanisms of neocortical and sensory hyperexcitability in Fragile X Syndrome
$1,748,274Kimberly M Huber · Ut Southwestern Medical Center · U54 · FY2016 · HD
Xenobiotic receptors
$1,748,246Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Comparative phenotypic, functional, and molecular analysis of ESC and iPSC
$1,748,199George Q Daley · Boston Children'S Hospital · RC2 · FY2009 · HL